← Every company
Genmab A/S SEC Filings
What Genmab A/S has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
GMAB overview →Filings on file
10
since May 28, 2019
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Feb 17, 2026 | Annual report 20-F | Read ↗ |
| Oct 21, 2025 | Tender offer SC TO-T | Read ↗ |
| Feb 12, 2025 | Annual report 20-F | Read ↗ |
| Feb 14, 2024 | Annual report 20-F | Read ↗ |
| Feb 22, 2023 | Annual report 20-F | Read ↗ |
| Feb 16, 2022 | Annual report 20-F | Read ↗ |
| Mar 29, 2021 | Annual report 20-F | Read ↗ |
| Mar 30, 2020 | Annual report 20-F | Read ↗ |
| Jul 19, 2019 | Share offering 424B4 | Read ↗ |
| May 28, 2019 | Share offering F-1 | Read ↗ |
Source: Genmab A/S's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.